First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy-Reference-Cited by-同舟云学术

First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy

Published:2014-09-05 Issue:12 Volume:99 Page:1784-1791
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Yoshida N.,Kobayashi R.,Yabe H.,Kosaka Y.,Yagasaki H.,Watanabe K.-i.,Kudo K.,Morimoto A.,Ohga S.,Muramatsu H.,Takahashi Y.,Kato K.,Suzuki R.,Ohara A.,Kojima S.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outpatient ATG-free hematopoietic transplantation for aplastic anemia in limited-resource environments offers excellent results: Data from a single LATAM center;Blood Cells, Molecules, and Diseases;2024-11

2. Accurate donor and recipient selection and a short time to transplant offer excellent outcomes in upfront hematopoietic stem cell transplantation from matched unrelated donors for pediatric severe aplastic anemia and refractory cytopenia of childhood. A study of the Spanish Pediatric Group for Hematopoietic Cell Transplantation and Cell Therapy (GETH-TC);Bone Marrow Transplantation;2024-09-03

3. Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic Anemia;Journal of Hematology;2024-08

4. Comparison of efficacy of eltrombopag combined with immunosuppression in the treatment of severe aplastic anemia and very severe aplastic anemia: real-world data and evidence;Annals of Hematology;2024-08-01

5. First-line treatment of severe aplastic anemia: immunosuppressive therapy plus eltrombopag versus haploidentical hematopoietic stem cell transplantation, a multicenter prospective study;Bone Marrow Transplantation;2024-08-01